ABSTRACT
Desonide is a topical corticoid used in the treatment of skin diseases and is marketed in different pharmaceutical dosage forms. Recently, the poor photostability of a commercially available hair solution after direct exposure to UVA light was verified. In this study, we investigated the ability of the antioxidants ascorbic acid, butylhydroxyanisole (BHA), butylhydroxytoluene (BHT), α-tocopherol, and the UV filter benzophenone-3 (BP-3) to prevent the photodegradation of desonide in hair solution (desonide 0.1%) and the stability of the proposed formulation under environmental conditions. The tested antioxidants were not able to prevent the photolysis of desonide, whereas the addition of 0.3% BP-3 enhanced the photostability of the drug. After 15 h of direct exposure to UVA radiation, the desonide remaining content in the hair solution with BP-3 was approximately 98%. Higher photostability was also verified under UVC radiation. Additionally, the results indicated that the formulation was stable under accelerated and room temperature conditions for 70 days, corresponding to the total period of the study.
Subject(s)
Antioxidants/chemistry , Benzophenones/chemistry , Dermatologic Agents/chemistry , Desonide/chemistry , Antioxidants/radiation effects , Benzophenones/radiation effects , Chemistry, Pharmaceutical , Dermatologic Agents/radiation effects , Desonide/radiation effects , Excipients , Photochemistry , Spectrophotometry, Ultraviolet , Temperature , Ultraviolet RaysABSTRACT
Tretinoin (TRE) is a widely used retinoid for the topical treatment of acne, psoriasis, skin cancer and photoaging. Despite unmatchable efficacy, it is associated with several vexatious side effects like marked skin erythema, peeling and irritation, eventually leading to poor patient compliance. Its photo-instability and high lipophilicity also pose challenges in the development of a suitable topical product. The present study, therefore, aims to develop biocompatible lipid-based nanocarriers of TRE to improve its skin delivery, photostability, biocompatibility and pharmacodynamic efficacy. The TRE-loaded liposomes, ethosomes, solid lipid nanoparticles (SLNs) and nanostructured lipidic carriers (NLCs) were prepared and characterized for micromeritics, surface charge, percent drug efficiency and morphology. Bioadhesive hydrogels of the developed systems were also evaluated for rheological characterization, photostability, ex vivo skin permeation and retention employing porcine skin, and anti-psoriatic activity in mouse tail model. Nanoparticulate carriers (SLNs, NLCs) offered enhanced photostability, skin transport and anti-psoriatic activity vis-à-vis the vesicular carriers (liposomes, ethosomes) and the marketed product. However, all the developed nanocarriers were found to be more biocompatible and effective than the marketed product. These encouraging findings can guide in proper selection of topical carriers among diversity of such available carriers systems.
Subject(s)
Dermatologic Agents/administration & dosage , Drug Carriers/administration & dosage , Psoriasis/drug therapy , Tretinoin/administration & dosage , Animals , Dermatologic Agents/chemistry , Dermatologic Agents/radiation effects , Drug Carriers/chemistry , Drug Carriers/radiation effects , Drug Stability , Ethanol/chemistry , Female , In Vitro Techniques , Lipids/chemistry , Mice , Nanostructures/administration & dosage , Nanostructures/chemistry , Skin Absorption , Sunlight , Tretinoin/chemistry , Tretinoin/radiation effectsABSTRACT
INTRODUCTION: Lipid nanoparticles are innovative carrier systems developed as an alternative to traditional vehicles such as emulsions, liposomes and polymeric nanoparticles. Solid lipid nanoparticles (SLN) and the newest nanostructured lipid carriers (NLC) show important advantages for dermal application of cosmetics and pharmaceuticals. AREA COVERED: This article focuses on the main features of lipid nanoparticles, in terms of their preparation and recent advancements. A detailed review of the literature is presented, introducing the importance of these systems in the topical delivery of drugs and active substances. EXPERT OPINION: Lipid nanoparticles are able to enhance drug penetration into the skin, allowing increased targeting to the epidermis and consequently increasing treatment efficiency and reducing the systemic absorption of drugs and cosmetic actives. The complete biodegradation of lipid nanoparticles and their biocompatible chemical nature have secured them the title of 'nanosafe carriers.' SLN and NLC represent a new technological era, which has been taken over by the cosmetic and pharmaceutical industry, which will open new channels for effective topical delivery of substances.
Subject(s)
Cosmetics/administration & dosage , Dermatologic Agents/administration & dosage , Drug Carriers , Lipids/administration & dosage , Nanoparticles/administration & dosage , Skin Diseases/drug therapy , Acne Vulgaris/drug therapy , Administration, Cutaneous , Administration, Topical , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Antifungal Agents/administration & dosage , Cosmetics/chemistry , Cosmetics/radiation effects , Dermatitis, Atopic/drug therapy , Dermatologic Agents/chemistry , Dermatologic Agents/pharmacokinetics , Dermatologic Agents/radiation effects , Drug Carriers/chemistry , Drug Stability , Emulsions , Excipients , Humans , Light , Lipids/chemistry , Lipids/pharmacokinetics , Lipids/radiation effects , Mycoses/drug therapy , Nanoparticles/chemistry , Nanoparticles/radiation effects , Psoriasis/drug therapy , Skin/metabolismABSTRACT
Carotenoids, natural pigments widely distributed in algae and plants, have a conjugated double bond system. Their excitation energies are correlated with conjugation length. We hypothesized that carotenoids whose energy states are above the singlet excited state of oxygen (singlet oxygen) would possess photosensitizing properties. Here, we demonstrated that human skin melanoma (A375) cells are damaged through the photo-excitation of several carotenoids (neoxanthin, fucoxanthin and siphonaxanthin). In contrast, photo-excitation of carotenoids that possess energy states below that of singlet oxygen, such as ß-carotene, lutein, loroxanthin and violaxanthin, did not enhance cell death. Production of reactive oxygen species (ROS) by photo-excited fucoxanthin or neoxanthin was confirmed using a reporter assay for ROS production with HeLa Hyper cells, which express a fluorescent indicator protein for intracellular ROS. Fucoxanthin and neoxanthin also showed high cellular penetration and retention. Electron spin resonance spectra using 2,2,6,6-tetramethil-4-piperidone as a singlet oxygen trapping agent demonstrated that singlet oxygen was produced via energy transfer from photo-excited fucoxanthin to oxygen molecules. These results suggest that carotenoids such as fucoxanthin, which are capable of singlet oxygen production through photo-excitation and show good penetration and retention in target cells, are useful as photosensitizers in photodynamic therapy for skin disease.
Subject(s)
Carotenoids/pharmacology , Dermatologic Agents/pharmacology , Photosensitizing Agents/pharmacology , Singlet Oxygen/metabolism , Xanthophylls/pharmacology , Carotenoids/radiation effects , Carotenoids/therapeutic use , Cytotoxins/pharmacology , Cytotoxins/radiation effects , Cytotoxins/therapeutic use , Dermatologic Agents/radiation effects , Dermatologic Agents/therapeutic use , Electron Spin Resonance Spectroscopy , HeLa Cells , Humans , Light , Photochemotherapy/methods , Photosensitizing Agents/radiation effects , Photosensitizing Agents/therapeutic use , Skin Diseases/drug therapy , Triacetoneamine-N-Oxyl/analogs & derivatives , Triacetoneamine-N-Oxyl/chemistry , Xanthophylls/radiation effects , Xanthophylls/therapeutic useABSTRACT
We, the Food and Drug Administration (FDA), are issuing this final rule to include benzoyl peroxide as a generally recognized as safe and effective (GRASE) active ingredient in over-the-counter (OTC) topical acne drug products. In addition, this final rule includes new warnings and directions required for OTC acne drug products containing benzoyl peroxide. We are also revising labeling for OTC topical acne drug products containing resorcinol, resorcinol monoacetate, salicylic acid and/or sulfur to meet OTC drug labeling content and format requirements in a certain FDA regulation. This final rule is part of our ongoing review of OTC drug products and represents our conclusions on benzoyl peroxide in OTC acne drug products.
Subject(s)
Acne Vulgaris/drug therapy , Benzoyl Peroxide/classification , Dermatologic Agents/classification , Drug Labeling/legislation & jurisprudence , Resorcinols/classification , Salicylic Acid/classification , Sulfur/classification , Administration, Topical , Animals , Benzoyl Peroxide/adverse effects , Benzoyl Peroxide/radiation effects , Benzoyl Peroxide/therapeutic use , Carcinogenicity Tests , Carcinogens , Dermatologic Agents/adverse effects , Dermatologic Agents/radiation effects , Dermatologic Agents/therapeutic use , Humans , Mice , Mutagenicity Tests , Mutagens , Nonprescription Drugs/adverse effects , Nonprescription Drugs/classification , Nonprescription Drugs/radiation effects , Nonprescription Drugs/therapeutic use , Resorcinols/adverse effects , Resorcinols/therapeutic use , Salicylic Acid/adverse effects , Salicylic Acid/therapeutic use , Sulfur/adverse effects , Sulfur/therapeutic use , Ultraviolet Rays/adverse effects , United StatesABSTRACT
The aim of this study was to prepare and characterize tretinoin-loaded nanocapsules as well as to evaluate the influence of this nanoencapsulation on tretinoin photostability. Tretinoin-loaded nanocapsules (0.5 mg ml(-1)) were prepared by interfacial deposition of preformed polymer (poly-epsilon-caprolactone) using two different oily phases: capric/caprylic triglycerides and sunflower seed oil. Tretinoin-loaded nanocapsules presented drug content close to the theoretical value, encapsulation efficiencies higher than 99.9%, nanometric mean size with a polydispersity index below 0.25, and pH values between 5.0 and 7.0. Regarding photodegradation studies, tretinoin methanolic solution showed a half-life time around 40 min according to a first order equation, whereas tretinoin nanocapsule suspensions showed a half-life between 85 and 100 min (twofold higher than in methanolic solution) according to a zero order equation. Tretinoin-loaded nanocapsules improved tretinoin photostability, independently on the type of oily phase used in this study, and represent a potential system to be incorporated in topical or systemic dosage forms containing tretinoin.
Subject(s)
Dermatologic Agents/radiation effects , Nanocapsules , Photolysis , Tretinoin/radiation effects , Ultraviolet Rays , Caprylates/chemistry , Chemistry, Pharmaceutical , Decanoic Acids/chemistry , Dermatologic Agents/chemistry , Drug Compounding , Drug Stability , Feasibility Studies , Half-Life , Kinetics , Particle Size , Plant Oils/chemistry , Polyesters/chemistry , Solubility , Sunflower Oil , Technology, Pharmaceutical/methods , Tretinoin/chemistry , Triglycerides/chemistryABSTRACT
The chemical stability of tretinoin (RA) and isotretinoin (13RA) in ethanol and dermatological cream preparations exposed to solar simulated light (SSL), UVA, and visible light has been studied. Photostability was monitored by an HPLC method that allowed simultaneous analysis of RA and 13RA, thus allowing photodegradation due to isomerization to other retinoids and photolysis to non-retinoid products to be monitored. Both retinoids undergo both isomerization and photolysis following SSL, UVA and visible light exposure but RA is more sensitive to photodegradation than 13RA. Degradation of both retinoids by photolysis is considerably greater in cream formulations than in ethanol and the photodegradation follows second order kinetics. Rate constants and half-lives for degradation of RA and 13RA in ethanol solution and cream preparations subjected to different light sources are reported. The UVA component of SSL is the major contributor to photodegradation. Since UVA penetrates deeply into skin, our results suggest that photodegradation of RA may contribute to the photosensitivity associated with RA therapy. Our studies suggest that development of improved formulations and the use of effective UVA sunscreens may reduce the side effects of RA therapy.
Subject(s)
Dermatologic Agents/radiation effects , Isotretinoin/radiation effects , Photolysis , Technology, Pharmaceutical/methods , Tretinoin/radiation effects , Ultraviolet Rays , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid , Dermatologic Agents/chemistry , Drug Compounding , Drug Stability , Ethanol/chemistry , Half-Life , Isotretinoin/chemistry , Kinetics , Light , Ointments , Sunlight , Tretinoin/chemistryABSTRACT
Psoralens are widely used for the treatment of hyperproliferative skin disease. In this work, we prepared nanoparticles (NP) containing a benzopsoralen (3-ethoxy carbonyl-2H-benzofuro[3,2-f]-1-benzopiran-2-one) by the solvent evaporation technique. We evaluated important NP parameters such as particle size, drug encapsulation efficiency, effect of the encapsulation process over the drug's photochemistry, zeta potential, external morphology, and in vitro release behavior. We also investigated the nanoparticle as a drug delivery system (DDS), as well as its target delivery to the action site, which is a very important parameter to increase the therapeutic use of psoralens and to reduce their side effects. The uptake of benzopsoralen-loaded PLGA nanoparticles by different kinds of cells found in rat peritoneal exudates was also studied. The photodamage promoted by irradiation with UV light revealed morphological characteristics of cell damage such as cytoplasmic vesiculation, mitochondrial damage, and swelling of both the granular endoplasmatic reticulum and nuclear membrane. This encapsulation method maintained the drug's properties and improved drug delivery to the target cell.